Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Merck shares hit record high after jump in profit

      Merck shares hit record high after jump in profit

      Ruby Khatun Khatun30 April 2018 9:30 AM IST
      Shares of Merck Ltd rose as much as 14.1 percent to their all-time high of Rs 2,172.8. The stock posted its biggest intraday percentage gain in a...
      Import banned, Only public sector to manufacture oxytocin

      Import banned, Only public sector to manufacture oxytocin

      Ruby Khatun Khatun29 April 2018 12:32 PM IST
      New Delhi: As part of its efforts to check the misuse of oxytocin by dairy operators and some farmers, the Ministry of Health has restricted its...
      Reliance Foundation Hospital appoints Dr Tarang Gianchandani as CEO

      Reliance Foundation Hospital appoints Dr Tarang Gianchandani as CEO

      Ruby Khatun Khatun29 April 2018 11:00 AM IST
      Mumbai: Reliance Foundation announced the appointment of Dr Tarang Gianchandani as the Chief Executive Officer of Sir H. N. Reliance Foundation...
      Soon, a new set of rules for e-pharmacies

      Soon, a new set of rules for e-pharmacies

      Ruby Khatun Khatun29 April 2018 10:30 AM IST
      New Delhi: The Health Ministry is planning to bring in a new set of regulations for the online sale of medicines, under which e-pharmacies will need...
      Fortis board to meet on May 10 to decide on binding bids

      Fortis board to meet on May 10 to decide on binding bids

      Ruby Khatun Khatun29 April 2018 10:30 AM IST
      New Delhi: Fortis Healthcare said its board will meet on May 10 to take a decision on the binding bids for the company as recommended by the expert...
      Gileads three-drug HIV regimen wins European panel approval

      Gilead's three-drug HIV regimen wins European panel approval

      Ruby Khatun Khatun29 April 2018 10:00 AM IST
      Gilead Sciences Inc said its three-drug regimen to treat HIV infection was recommended for approval by a panel of the European Medicines Agency,...
      Allergan migraine drug succeeds in second late-stage trial

      Allergan migraine drug succeeds in second late-stage trial

      Ruby Khatun Khatun29 April 2018 9:45 AM IST
      NEW YORK: Allergan Plc announced positive results from a second Phase III trial for the 50-milligram dose of its drug for acute migraine, reproducing...
      AbbVies beat fueled by demand for Humira, Hep C drugs

      AbbVie's beat fueled by demand for Humira, Hep C drugs

      Ruby Khatun Khatun29 April 2018 9:30 AM IST
      AbbVie Inc reported a better-than-expected quarterly profit, on higher sales of its rheumatoid arthritis treatment Humira and its Hepatitis C drugs,...
      NPPA fixes the price of Roseday, Volini Maxx Spray, BCG Vaccine, and more, check out details

      NPPA fixes the price of Roseday, Volini Maxx Spray, BCG Vaccine, and more, check out details

      Ruby Khatun Khatun28 April 2018 5:12 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
      Biocon Q4 net profit up 2 percent at Rs 130 crore; FY18 net dips 39 percent

      Biocon Q4 net profit up 2 percent at Rs 130 crore; FY18 net dips 39 percent

      Ruby Khatun Khatun28 April 2018 10:30 AM IST
      New Delhi: Biotechnology major Biocon posted 2 percent increase in its consolidated net profit at Rs 130 crore for the fourth quarter ended March of...
      MES Launches YO Home Sperm Test in India

      MES Launches YO Home Sperm Test in India

      Ruby Khatun Khatun28 April 2018 10:00 AM IST
      Mumbai: Medical Electronic Systems (MES), a Los Angeles based technology company specializing in rapid Automated Semen Analysis, announced the launch...
      UK healthcare startup Cera is said to have posted fake reviews

      UK healthcare startup Cera is said to have posted fake reviews

      Ruby Khatun Khatun28 April 2018 9:45 AM IST
      U.K. healthcare startup Cera Care has attracted more than $4 million in venture funding and amassed a roster of advisory board members that includes a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok